Medtronic plc Stock
€81.80
Your prediction
Medtronic plc Stock
Pros and Cons of Medtronic plc in the next few years
Pros
Cons
Performance of Medtronic plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medtronic plc | -0.500% | -1.851% | -4.695% | -4.418% | 0.207% | 2.417% | -13.672% |
| Dentsply Sirona Inc. | -1.220% | -2.521% | -3.886% | -40.620% | 10.897% | -67.909% | -75.585% |
| Dexcom Inc. | -0.690% | 5.120% | -1.478% | -26.947% | 8.165% | -41.154% | -26.844% |
| Teleflex Inc. | -1.530% | 12.000% | 10.112% | -40.964% | -3.922% | -55.856% | -68.790% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon first glance at Medtronic's financials, the company appears to be a strong player in the Healthcare Equipment & Supplies sector. Over the years, Medtronic has demonstrated relatively stable financial performance, which is a desirable attribute for a healthcare company. However, more in-depth analysis is needed to better understand the pros and cons of its financial situation.
Revenue Growth: Medtronic's total revenue has experienced consistent growth over the last three years as seen in the yearly income statements. In 2020, the company recorded total revenue of $28.913 billion which increased to $30.117 billion in 2021, and further to $31.686 billion in 2022.
Increasing Gross Profit: Medtronic has seen a rise in its gross profit, from $19.489 billion in 2020 to $19.634 billion in 2021, and eventually $21.541 billion in 2022. This implies that the company is becoming more efficient in its manufacturing and supply chain activities, which is a good sign for potential investors.
Comments
News
1 Reason I'd Buy Medtronic Stock and Never Sell
The bull case for any stock often rests on several aspects of the business. That certainly applies to Medtronic (NYSE: MDT), a healthcare leader. Bulls could point to many reasons the stock is worth
Dividend Medtech Giant Medtronic Is Built to Survive Any Market Crash
The terms "dividend" and "healthcare stock" usually aren't mentioned in the same sentence. They're almost unavoidable together when talking about Medtronic (NYSE: MDT), however. The company is not
The Only Healthcare Stock I Would Buy and Never Sell Is Medtronic
I am not a scientist or a medical doctor, so I'm a bit leery of buying healthcare stocks. I've actually outsourced this task to BlackRock Health Sciences Trust (NYSE: BME), a high-yield closed-end